The cost-effectiveness of Ustekinumab in moderate to severely active crohn’s disease in Sweden

Authors:

Hansson-Hedblom A, Almond C, Borgström F, Sly I, Enkusson D, Troelsgaard Buchholt A and Karlsson L

Publication type:

Poster PGI17

Conference name:

20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Hansson-Hedblom A, Almond C, Borgström F, Sly I, Enkusson D, Troelsgaard Buchholt A and Karlsson L. The cost-effectiveness of Ustekinumab in moderate to severely active crohn’s disease in Sweden. 20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Glasgow, Scotland. 4-8 November. Poster PGI17.

Link to publication ⟶

⟵ Back to Search Results